Management of chronic uveitis.
作者信息
McCluskey P J, Towler H M, Lightman S
机构信息
Department of Ophthalmology, St Vincent's Hospital, Sydney, NSW, Australia.
出版信息
BMJ. 2000 Feb 26;320(7234):555-8. doi: 10.1136/bmj.320.7234.555.
Abstract
摘要
相似文献
1
Management of chronic uveitis.
BMJ. 2000 Feb 26;320(7234):555-8. doi: 10.1136/bmj.320.7234.555.
2
[Traumatic uveitis: the problem of pathogenetic therapy].
Vestn Oftalmol. 1998 Mar-Apr;114(2):53-6.
3
[Etiological diagnosis of uveitis and therapeutic management].
Bull Soc Ophtalmol Fr. 1976 Sep-Oct;76(9-10):839-46.
4
Uveitis management: a multidisciplinary approach to assess systemic involvement and side effects of treatments.
Acta Clin Belg. 2002 Jun-Jul;57(3):142-7. doi: 10.1179/acb.2002.030.
5
Investigation and management of uveitis.
BMJ. 2010 Oct 13;341:c4976. doi: 10.1136/bmj.c4976.
6
The uvea.
Arch Ophthalmol. 1972 Jun;87(6):713-25. doi: 10.1001/archopht.1972.01000020715019.
7
Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients.
Eye (Lond). 2009 Nov;23(11):2034-41. doi: 10.1038/eye.2008.397. Epub 2009 Jan 16.
8
[Uveitis in children: about 20 cases].
J Fr Ophtalmol. 2003 Jun;26(6):609-13.
9
[Therapy of intermediate uveitis].
Ophthalmologe. 2014 Dec;111(12):1219-32; quiz 1233-4. doi: 10.1007/s00347-014-3201-2.
10
Management of Uveitis in Spondyloarthropathy: Current Trends.
Perm J. 2018;22:17-041. doi: 10.7812/TPP/17-041.
引用本文的文献
1
Neural networks for predicting etiological diagnosis of uveitis.
Eye (Lond). 2025 Apr;39(5):992-1002. doi: 10.1038/s41433-024-03530-2. Epub 2024 Dec 20.
2
Causal relationship between ankylosing spondylitis and ocular inflammatory diseases: a Mendelian randomization study.
Front Genet. 2024 Oct 17;15:1372196. doi: 10.3389/fgene.2024.1372196. eCollection 2024.
3
Efficacy and safety of single-dose intravitreal dexamethasone implant in non-infectious uveitic macular edema: A systematic review and meta-analysis.
Front Med (Lausanne). 2023 Feb 17;10:1126724. doi: 10.3389/fmed.2023.1126724. eCollection 2023.
4
Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis.
Front Pharmacol. 2022 Apr 5;13:749312. doi: 10.3389/fphar.2022.749312. eCollection 2022.
5
Signature of Circulating Biomarkers in Recurrent Non-Infectious Anterior Uveitis. Immunomodulatory Effects of DHA-Triglyceride. A Pilot Study.
Diagnostics (Basel). 2021 Apr 19;11(4):724. doi: 10.3390/diagnostics11040724.
6
Metabolomic Analysis of Aqueous Humor Identifies Aberrant Amino Acid and Fatty Acid Metabolism in Vogt-Koyanagi-Harada and Behcet's Disease.
Front Immunol. 2021 Feb 22;12:587393. doi: 10.3389/fimmu.2021.587393. eCollection 2021.
7
Characterization of Clinical and Immune Responses in an Experimental Chronic Autoimmune Uveitis Model.
Am J Pathol. 2021 Mar;191(3):425-437. doi: 10.1016/j.ajpath.2020.09.004. Epub 2020 Sep 20.
8
Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.
Drug Deliv Transl Res. 2021 Jun;11(3):866-893. doi: 10.1007/s13346-020-00843-z.
9
The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW.
RMD Open. 2020 Apr;6(1). doi: 10.1136/rmdopen-2019-001161.
10
Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy.
J Clin Med. 2020 Feb 13;9(2):510. doi: 10.3390/jcm9020510.
本文引用的文献
1
Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis.
Ocul Immunol Inflamm. 1995;3(3):163-70. doi: 10.3109/09273949509069109.
2
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7462-6. doi: 10.1073/pnas.96.13.7462.
3
Assessment of visual outcome after cataract surgery in patients with uveitis.
Ophthalmology. 1999 Apr;106(4):710-22. doi: 10.1016/S0161-6420(99)90155-0.
4
Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.
Ophthalmology. 1999 Feb;106(2):370-4. doi: 10.1016/S0161-6420(99)90078-7.
5
Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.
Ophthalmology. 1998 Jan;105(1):46-56. doi: 10.1016/s0161-6420(98)91176-9.
6
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial.
Am J Ophthalmol. 1997 May;123(5):583-92. doi: 10.1016/s0002-9394(14)71070-0.
7
Ocular tuberculosis. A prospective study in a general hospital.
Medicine (Baltimore). 1997 Jan;76(1):53-61. doi: 10.1097/00005792-199701000-00005.
8
The possible impact of uveitis in blindness: a literature survey.
Br J Ophthalmol. 1996 Sep;80(9):844-8. doi: 10.1136/bjo.80.9.844.
9
Causes and frequency of blindness in patients with intraocular inflammatory disease.
Br J Ophthalmol. 1996 Apr;80(4):332-6. doi: 10.1136/bjo.80.4.332.
10
An intravitreal device providing sustained release of cyclosporine and dexamethasone.
Curr Eye Res. 1996 May;15(5):549-57. doi: 10.3109/02713689609000766.
Zotero 插件